(STL.News) Researchers at the National Institute for Allergies and Infectious Diseases which co-developed the drug, studied the immune response of 34 adult participants, young and old, from the first stage of a clinical trial.

YouTube video provided courtesy of WION News

STL.News References:

  1. YouTube

By STLNEWS

STL.News is owned and operated by STL.News, LLC. We publish States Top Leading News. Our news is timely, unbiased and content is obtained direct from the source to obtain reliable information. Additionally, we will publish YouTube news video from major media companies.